Medical Director

Yiping Shen is an ABMG-board certified medical director at Claritas. He has over 20 years’ experience in human genetic research and over 10 years’ experience in clinical molecular testing service. He also directed the R&D activity at the Genetic Diagnostic Laboratory (GDL) at Boston Children’s Hospital and developed and updated many tests including MLPA based targeted copy number tests, the microarray-based whole genome CNV+SNP test, as well as Sanger- and Next Generation Sequencing-based tests. He co-directs the R&D group at Claritas. He has published numerous articles on the discovery of novel disease genes and contributed to a better understanding of genotype-phenotype correlations that are the basis for clinical interpretation and counseling. His research interests in understanding the genetic causes of pediatric genetic disorders, particularly developmental disorders, provide unique value for the genetic diagnostic testing service for the pediatric patient population at Claritas. Dr. Shen is a reviewer for more than twenty academic journals and had been invited for countless talks nationally and internationally. He also provides training for research and clinical fellows and teaches for the Harvard Genetic Training Program from which he was initially trained. He is an assistant professor at the Pathology Department at Harvard Medical School. He is also on the Faculty at Jiaotong University in Shanghai. Dr. Shen received the Master of Science in Developmental Biology at Wuhan University, China. He received his PhD in Pharmacology from Upstate Medical University, Syracuse, New York. He did his clinical genetics fellowship training in the Harvard Medical School Genetics Training Program. He is board-certified in Clinical Molecular Genetics. He is a Diplomat of the American Board of Medical Genetics, a fellow of American College of Medical Genetics and a leadership committee member of Chinese Medical Doctor Association.